This Electric Vehicle Stock Is Your Backdoor Play into the Surging Industry

Michael A. Robinson

My 2019 Acura MDX often reminds me of a standard line from old Westerns.

In so many of those classic films, a hero would sum up the atmosphere right before a climactic gun battle by saying, "It's quiet, too quiet."

See, my hybrid comes equipped with three electric motors. Sometimes, when I'm at a traffic light or idling the car in the driveway, the MDX is so quiet that I will check to make sure the engine really is running.

Well, fasten your seat belts folks – cars across the board are about to become just as silent.

They're also going to become much more fuel-efficient, as the center of gravity in the auto industry shifts from gas-powered units to hybrids and electrics, also known as EVs.

If you have any doubt that this is an unstoppable trend in the $1.7 trillion global auto sector, then consider the recent big racket made by Volkswagen AG (OTCMKTS: VWAGY).

The company just stepped up its commitment to EVs by saying it intends to produce 22 million of them in the next decade alone.

And I've uncovered an electric vehicle stock that's is a play on the entire EV movement. It's like owning an exchange traded fund (ETF) on the future of auto technology…

Check it out…

The EV Catalyst

Now then, it's not exactly accurate to say that VW is doubling down on electrics. But the new forecast is a 46% increase from its previous goal of putting 15 million EVs on the world's highways.

Make no mistake. This will be a gig catalyst for the entire EV movement.

Brace Yourself: The 5G Revolution Is Unleashing Your Next Potential TRILLION-DOLLAR Opportunity – Go Here Now

VW ranks as the world's top-selling car firm, having outsold Toyota since 2016. It projects that 40% of all its cars will be electrics within in just a few years, and will be carbon neutral by 2050.

That puts VW at the forefront of a global car segment that Allied Market Research says is growing by more than 22% a year. The firm forecasts EV sales of $567 billion by 2025, up 380.5% from the base year of 2017.

Clearly, this is a target rich environment for a savvy auto supplier that knows how to make key EV components for the global car sector.

And that's why savvy tech investors ought to take a good look under the hood at this EV stock…

Michael A. Robinson

About the Author

Browse Michael's articles | View Michael's research services

Michael A. Robinson is a 36-year Silicon Valley veteran and one of the top tech and biotech financial analysts working today. That's because, as a consultant, senior adviser, and board member for Silicon Valley venture capital firms, Michael enjoys privileged access to pioneering CEOs, scientists, and high-profile players. And he brings this entire world of Silicon Valley "insiders" right to you...

• He was one of five people involved in early meetings for the $160 billion "cloud" computing phenomenon.
• He was there as Lee Iacocca and Roger Smith, the CEOs of Chrysler and GM, led the robotics revolution that saved the U.S. automotive industry.
• As cyber-security was becoming a focus of national security, Michael was with Dave DeWalt, the CEO of McAfee, right before Intel acquired his company for $7.8 billion.

This all means the entire world is constantly seeking Michael's insight.

In addition to being a regular guest and panelist on CNBC and Fox Business, he is also a Pulitzer Prize-nominated writer and reporter. His first book Overdrawn: The Bailout of American Savings warned people about the coming financial collapse - years before the word "bailout" became a household word.

Silicon Valley defense publications vie for his analysis. He's worked for Defense Media Network and Signal Magazine, as well as The New York Times, American Enterprise, and The Wall Street Journal.

And even with decades of experience, Michael believes there has never been a moment in time quite like this.

Right now, medical breakthroughs that once took years to develop are moving at a record speed. And that means we are going to see highly lucrative biotech investment opportunities come in fast and furious.

To help you navigate the historic opportunity in biotech, Michael launched the Bio-Tech Profit Alliance.

His other publications include: Strategic Tech Investor, The Nova-X Report, Bio-Technology Profit Alliance and Nexus-9 Network.

… Read full bio